NCT01997528

Brief Summary

Oxygenatuion and decarboxylation during different settings (steps of blood flow and sweep gas flow) of extracorporeal gas exchange by ILA Activve using a jugular 22French double lumen cannula are measured.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2013

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 28, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Last Updated

November 28, 2013

Status Verified

November 1, 2013

Enrollment Period

1 year

First QC Date

November 7, 2013

Last Update Submit

November 22, 2013

Conditions

Hypercapnia

Outcome Measures

Primary Outcomes (1)

  • Blood gas analysis

    Changes after every 15 min. of each setting (13 settings leading to 195 min. altogether)

Study Arms (1)

Extracorporeal CO2 elimination by ILA Activve(R)

EXPERIMENTAL
Device: Change of blood flow or sweep gas flow ( ILA Activve)

Interventions

Change of blood flow or sweep gas flow ( ILA Activve)DEVICE
Extracorporeal CO2 elimination by ILA Activve(R)

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient on ILA Activve
  • Controlled mechanical ventilation
  • No spontaneous breathing

You may not qualify if:

  • \- Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Medicine I, ICU, General Hospital of Vienna

Vienna, Vienna, 1090, Austria

RECRUITING

MeSH Terms

Conditions

Hypercapnia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Thomas Staudinger, MD

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ao. Univ.-Prof. Dr.

Study Record Dates

First Submitted

November 7, 2013

First Posted

November 28, 2013

Study Start

November 1, 2013

Primary Completion

November 1, 2014

Last Updated

November 28, 2013

Record last verified: 2013-11

Locations

AU(1)